• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰高血糖素样肽-1(7-36)酰胺可改善非肥胖糖尿病(NOD)小鼠β细胞的葡萄糖敏感性。

Glucagon-like-peptide-1 (7-36) amide improves glucose sensitivity in beta-cells of NOD mice.

作者信息

Linn T, Schneider K, Göke B, Federlin K

机构信息

Medical Clinic III and Polyclinic, Justus Liebig University, Giessen, Germany.

出版信息

Acta Diabetol. 1996 Mar;33(1):19-24. doi: 10.1007/BF00571935.

DOI:10.1007/BF00571935
PMID:8777280
Abstract

The effect of the insulinotropic gut hormone glucagon-like-peptide-1 (GLP-1) was studied on the residual insulin capacity of prediabetic nonobese diabetic (NOD) mice, a model of insulin-dependent diabetes mellitus (type 1). This was done using isolated pancreas perfusion and dynamic islet perifusion. Prediabetes was defined by insulitis and fasting normoglycemia. Insulitis occurred in 100% of NOD mice beyond the age of 12 weeks. K values in the intravenous glucose tolerance test were reduced in 20-week-old NOD mice compared with age matched non-diabetes-prone NOR (nonobese resistant) mice (2.4 +/- 1.1 vs 3.8 +/- 1.5% min-1, P < 0.05). Prediabetic NOD pancreases were characterized by a complete loss of the glucose-induced first-phase insulin release. In perifused NOD islets GLP-1, at concentrations already effective in normal islets, left the insulin release unaltered. However, a significant rise of glucose-dependent insulin secretion occurred for GLP-1 concentrations > 0.1 nM. This was obtained with both techniques, dynamic islet perifusion and isolated pancreas perfusion, indicating a direct effect of GLP-1 on the beta-cell. Analysis of glucose-insulin dose-response curves revealed a marked improvement of glucose sensitivity of the NOD endocrine pancreas in the presence of GLP-1 (half-maximal insulin output without GLP-1 15.2 mM and with GLP-1 9.4 mM, P < 0.002). We conclude that GLP-1 can successfully reverse the glucose sensing defect of islets affected by insulitis.

摘要

研究了促胰岛素肠道激素胰高血糖素样肽-1(GLP-1)对胰岛素依赖型糖尿病(1型)的糖尿病前期非肥胖糖尿病(NOD)小鼠残余胰岛素分泌能力的影响。采用离体胰腺灌注和动态胰岛灌流技术进行研究。糖尿病前期通过胰岛炎和空腹血糖正常来定义。12周龄以上的NOD小鼠100%发生胰岛炎。与年龄匹配的非糖尿病易感性NOR(非肥胖抗性)小鼠相比,20周龄NOD小鼠静脉葡萄糖耐量试验中的K值降低(2.4±1.1对3.8±1.5%min-1,P<0.05)。糖尿病前期NOD胰腺的特征是葡萄糖诱导的第一相胰岛素释放完全丧失。在灌流的NOD胰岛中,GLP-1在对正常胰岛已经有效的浓度下,胰岛素释放未改变。然而,对于GLP-1浓度>0.1 nM,葡萄糖依赖性胰岛素分泌显著增加。动态胰岛灌流和离体胰腺灌注这两种技术均得到此结果,表明GLP-1对β细胞有直接作用。葡萄糖-胰岛素剂量反应曲线分析显示,在存在GLP-1的情况下,NOD内分泌胰腺的葡萄糖敏感性显著改善(无GLP-1时胰岛素输出的半数最大值为15.2 mM,有GLP-1时为9.4 mM,P<0.002)。我们得出结论,GLP-1可以成功逆转受胰岛炎影响的胰岛的葡萄糖感知缺陷。

相似文献

1
Glucagon-like-peptide-1 (7-36) amide improves glucose sensitivity in beta-cells of NOD mice.胰高血糖素样肽-1(7-36)酰胺可改善非肥胖糖尿病(NOD)小鼠β细胞的葡萄糖敏感性。
Acta Diabetol. 1996 Mar;33(1):19-24. doi: 10.1007/BF00571935.
2
Priming effect of glucagon-like peptide-1 (7-36) amide, glucose-dependent insulinotropic polypeptide and cholecystokinin-8 at the isolated perfused rat pancreas.胰高血糖素样肽-1(7-36)酰胺、葡萄糖依赖性促胰岛素多肽及胆囊收缩素-8对离体灌注大鼠胰腺的启动效应
Biochim Biophys Acta. 1991 Feb 19;1091(3):356-63. doi: 10.1016/0167-4889(91)90200-h.
3
Glucagon-like peptide-1(7-36)-amide confers glucose sensitivity to previously glucose-incompetent beta-cells in diabetic rats: in vivo and in vitro studies.胰高血糖素样肽-1(7-36)酰胺赋予糖尿病大鼠中先前对葡萄糖无反应的β细胞葡萄糖敏感性:体内和体外研究
J Endocrinol. 1997 Nov;155(2):369-76. doi: 10.1677/joe.0.1550369.
4
Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas.胰高血糖素样肽I增强了格列本脲对非胰岛素依赖型糖尿病患者及灌注大鼠胰腺的促胰岛素分泌作用。
Diabetes Care. 1996 Aug;19(8):857-63. doi: 10.2337/diacare.19.8.857.
5
Altered glucose dependence of glucagon-like peptide I(7-36)-induced insulin secretion from the Zucker (fa/fa) rat pancreas.胰高血糖素样肽I(7-36)诱导的来自Zucker(fa/fa)大鼠胰腺的胰岛素分泌的葡萄糖依赖性改变。
Diabetes. 1995 May;44(5):495-500. doi: 10.2337/diab.44.5.495.
6
Glucose-dependency of the insulin stimulatory effect of glucagon-like peptide-1 (7-36) amide on the rat pancreas.
Res Exp Med (Berl). 1993;193(2):97-103. doi: 10.1007/BF02576216.
7
Insulinotropic effects of cholecystokinin, gastric inhibitory polypeptide and glucagon-like peptide-1 during perifusion of short-term cultured canine isolated islets.胆囊收缩素、胃抑制多肽和胰高血糖素样肽-1在短期培养的犬分离胰岛灌注期间的促胰岛素分泌作用
Regul Pept. 1995 Dec 7;60(1):61-7. doi: 10.1016/0167-0115(95)00122-4.
8
Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets.胰高血糖素样肽1抑制细胞凋亡并改善新鲜分离的人胰岛的葡萄糖反应性。
Endocrinology. 2003 Dec;144(12):5149-58. doi: 10.1210/en.2003-0323. Epub 2003 Aug 28.
9
The effects of glucagon-like peptide-I (GLP-I) on hormone secretion from isolated human pancreatic islets.胰高血糖素样肽-1(GLP-1)对分离的人胰岛激素分泌的影响。
Pancreas. 1995 Aug;11(2):196-200. doi: 10.1097/00006676-199508000-00014.
10
Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDM.通过对非胰岛素依赖型糖尿病患者夜间输注胰高血糖素样肽1(7-36)酰胺使胰岛素对葡萄糖的反应正常化。
Diabetes. 1996 Nov;45(11):1524-30. doi: 10.2337/diab.45.11.1524.

引用本文的文献

1
Effects of dulaglutide and trelagliptin on beta-cell function in patients with type 2 diabetes: a randomized controlled study: DUET-beta study.度拉糖肽和曲格列汀对2型糖尿病患者β细胞功能的影响:一项随机对照研究:DUET-β研究
Diabetol Int. 2024 Apr 3;15(3):474-482. doi: 10.1007/s13340-024-00717-6. eCollection 2024 Jul.
2
Repurposing of existing antibiotics for the treatment of diabetes mellitus.现有抗生素重新用于治疗糖尿病。
In Silico Pharmacol. 2022 Mar 5;10(1):4. doi: 10.1007/s40203-021-00118-6. eCollection 2022.
3
Myricetin: a potent approach for the treatment of type 2 diabetes as a natural class B GPCR agonist.

本文引用的文献

1
Glucose-dependency of the insulin stimulatory effect of glucagon-like peptide-1 (7-36) amide on the rat pancreas.
Res Exp Med (Berl). 1993;193(2):97-103. doi: 10.1007/BF02576216.
2
Glucagon-like peptide-I-(7-37) suppresses hyperglycemia in rats.胰高血糖素样肽-1-(7-37)可抑制大鼠的高血糖。
Metabolism. 1993 Jan;42(1):1-6. doi: 10.1016/0026-0495(93)90163-i.
3
Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.2型糖尿病患者中胰高血糖素样肽1[7-36酰胺]的肠促胰岛素活性得以保留,但合成人胃抑制多肽的肠促胰岛素活性未保留。
杨梅素:作为一种天然的B类G蛋白偶联受体激动剂,是治疗2型糖尿病的有效方法。
FASEB J. 2017 Jun;31(6):2603-2611. doi: 10.1096/fj.201601339R. Epub 2017 Mar 7.
4
Novel application of hydrophobin in medical science: a drug carrier for improving serum stability.疏水蛋白在医学中的新应用:一种用于提高血清稳定性的药物载体。
Sci Rep. 2016 May 23;6:26461. doi: 10.1038/srep26461.
5
The Type 1 Diabetes PhysioLab Platform: a validated physiologically based mathematical model of pathogenesis in the non-obese diabetic mouse.1 型糖尿病生理实验室平台:一种经过验证的非肥胖型糖尿病小鼠发病机制的基于生理学的数学模型。
Clin Exp Immunol. 2010 Aug;161(2):250-67. doi: 10.1111/j.1365-2249.2010.04166.x. Epub 2010 May 18.
6
Exendin-4 modulates diabetes onset in nonobese diabetic mice.艾塞那肽-4调节非肥胖糖尿病小鼠的糖尿病发病。
Endocrinology. 2008 Mar;149(3):1338-49. doi: 10.1210/en.2007-1137. Epub 2007 Dec 6.
J Clin Invest. 1993 Jan;91(1):301-7. doi: 10.1172/JCI116186.
4
Cloning and functional expression of the human islet GLP-1 receptor. Demonstration that exendin-4 is an agonist and exendin-(9-39) an antagonist of the receptor.人胰岛胰高血糖素样肽-1受体的克隆与功能表达。证明艾塞那肽-4是该受体的激动剂,而艾塞那肽-(9-39)是其拮抗剂。
Diabetes. 1993 Nov;42(11):1678-82. doi: 10.2337/diab.42.11.1678.
5
Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37).胰腺β细胞通过促胰岛素激素胰高血糖素样肽-1(7-37)具备对葡萄糖的敏感性。
Nature. 1993 Jan 28;361(6410):362-5. doi: 10.1038/361362a0.
6
Spontaneous glucose intolerance in the progeny of low dose streptozotocin-induced diabetic mice.低剂量链脲佐菌素诱导的糖尿病小鼠后代中的自发性葡萄糖不耐受。
Diabetologia. 1993 Dec;36(12):1245-51. doi: 10.1007/BF00400801.
7
Detection of the human glucagon-like peptide 1(7-36) amide receptor on insulinoma-derived cell membranes.
Digestion. 1994;55(1):29-33. doi: 10.1159/000201119.
8
The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-37) in normal and diabetic subjects.葡萄糖依赖性促胰岛素多肽(GIP)和胰高血糖素样肽-1(7-37)在正常和糖尿病受试者中的促胰岛素作用。
Regul Pept. 1994 Apr 14;51(1):63-74. doi: 10.1016/0167-0115(94)90136-8.
9
International Symposium on Glucagon-Like Peptide-1. Copenhagen, Denmark, May 17-19, 1993. Abstracts.胰高血糖素样肽-1国际研讨会。丹麦哥本哈根,1993年5月17 - 19日。摘要
Digestion. 1993;54(6):337-97. doi: 10.1159/000201053.
10
Signal transduction of the GLP-1-receptor cloned from a human insulinoma.从人胰岛素瘤中克隆出的胰高血糖素样肽-1受体的信号转导
FEBS Lett. 1994 Jul 4;348(1):7-13. doi: 10.1016/0014-5793(94)00553-2.